Co-trimoxazole-induced reproductive toxicity and placental-barrier disruption: impact on cell-cell junctions and ERK signaling pathway.

Authors

Mehrdad Azarmi, Hassan Saei, I A C van Vugt, Suzan Thijssen, Belinda van 't Land, Ruurd van Elburg, Johan Garssen, Gert Folkerts, Astrid Hogenkamp, Saskia Braber

Published in

Frontiers in cell and developmental biology. Volume 14. Pages 1800328. Epub Jun 08, 2026.

Abstract

Co-trimoxazole (CTX), a combination of sulfamethoxazole (SMZ) and trimethoprim (TMP), is used during pregnancies complicated by infections like Urinary Tract Infections (UTI) and Human Immunodeficiency Virus (HIV), despite potential fetal safety concerns. This study examines CTX's effects on the placenta using both in vivo and in vitro models. Pregnant mice received CTX for 4 days during both early and late gestation. On gestational day 19, tissues were collected for analysis. Furthermore, in vitro, human BeWo placental cells were exposed to non-cytotoxic concentrations of CTX for 24 h. Gene expression was analyzed by bulk RNA sequencing with pathway analysis, and placental barrier function was assessed by measuring transepithelial electrical resistance (TEER) and fluorescein isothiocyanate-dextran (FITC-D) permeability. In vivo, CTX significantly reduced uterine weight and litter size (p < 0.05), indicating potential reproductive toxicity, which was supported by placental transcriptomic analysis. In vitro, bulk RNA-sequencing of CTX-treated BeWo cells exhibited differential expression of genes related to tight and adherens junctions, indicating impaired placental barrier integrity. This was accompanied by a significant reduction in TEER (p < 0.0001) and an increase in FITC-D permeability (p < 0.001). In addition, CTX activated the ERK1/2 (MAPK3) pathway, as indicated by increased ERK1/2 (p < 0.01) phosphorylation and downregulation of the ERK pathway negative regulators (DUSP genes). Additionally, IL-6 expression levels were reduced in the amniotic fluid (p < 0.01) and placenta of CTX-treated mice, and a similar reduction was observed in CTX-treated BeWo cells at both the transcript (p < 0.05) and protein (p < 0.001) levels. In conclusion, CTX may induce reproductive toxicity and compromise placental barrier integrity, warranting further investigation into its safety during pregnancy.

PMID:
42339266
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.